2017 CCNP Annual Meeting

CCNP 40th Annual Meeting

June 7 to 9, 2017

Kingston, Ontario


The registration website is closed but you can register onsite.
Only cash and cheques are accepted.

Dear Colleagues

The Canadian College of Neuropsychopharmacology 2017 Meeting will be held at the Four Points by Sheraton Hotel in the heart of Kingston, ON, June 7-9, 2017.

The 2017 Conference theme will be ‘Clinical and Basic Sciences Research Advancing Our Understanding of Brain Function and Treatment Approaches’. This meeting will also highlight the work and findings of several integrated discovery programs funded by the Ontario Brain Institute, followed by a panel discussion involving OBI President, Tom Mikkelsen.

Poster submissions should include (1) Title, (2) List of authors with affiliations, (3) Abstract: introduction, methods, results and conclusions (maximum 300 words). The local organizing committee encourages multi-institutional submissions with a translational component and a mix of junior and senior researchers. We encourage individuals from equity seeking groups such as women, racialized/visible minorities, Aboriginal peoples, persons with a disability and others who reflect the diversity of Canadian society to be included as presenters.

This conference is particularly oriented towards enhancing the training of the next generation as it includes the opportunity for selected graduate students/or postdoctoral students to present and offers a discounted registration rate for trainees

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada, and approved by Queen's University, You may claim a maximum of 20 hours.

We look forward to seeing you in Kingston!

Full Meeting Program available


The Canadian College of Neuropsychopharmacology appreciates the support of the following meeting sponsors:

Pfizer CIHR Ontario Brain Institute
Lundbeck Sunovion Allergan
Janssen Queen's University - Faculty of Health Sciences Lallemand
Queen's University - Department of Psychiatry Queen's University - Research Services Kingston
HLS Therapeutics Inc. Merck  

Journal of Psychiatry & Neuroscience

The official journal of the Canadian College of Neuropsychopharmacology
  • The Journal of Psychiatry & Neuroscience has an impact factor of 5.86 (2015 ISI data) and is ranked at #15 out of 140 Psychiatry journals and #29 out of 252 Neuroscience journals, making it the highest ranking open access journal in biological psychiatry.
  • Original research and reviews in basic and clinical science.
  • Articles published in the journal are available free of charge at http://jpn.ca and through PubMed Central.
For more information, visit the website of the Canadian Medical Association.

Revue de psychiatrie & de neuroscience

La revue officielle du Collège canadien de neuropsychopharmacologie
  • Le facteur d'impact de la Revue de psychiatrie et de neuroscience atteint 5,86 (données 2015 de l'ISI), ce qui en fait le journal à accès libre le mieux coté aussi bien dans la catégorie psychiatrie que dans la catégorie neurosciences.
  • Recherche originale et analyses critiques en sciences
      fondamentales et cliniques.
  • Les articles publiés dans ce journal sont accessibles gratuitement au http://jpn.ca/ et via PubMed Central.
Pour obtenir des informations suplémentaires, visitez le site internet de l'Association Médicale Canadienne.